Trial Profile
A Trial of Thymalfasin With Trans Arterial Chemo-Embolization (TACE) in the Treatment of Adult Patients With Unresectable Hepatocellular Carcinoma: A Phase II Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Thymalfasin (Primary) ; Antineoplastics
- Indications Liver cancer
- Focus Therapeutic Use
- 14 Jan 2008 Status changed to completed.
- 25 Aug 2005 New trial record.